vimarsana.com

Page 5 - மாற்று முதலீடு நிதி மேலாளர்கள் உத்தரவு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

JPMorgan European Discovery Trust NAV rises by 66 2% outperforming benchmark by 8 3%

JPMorgan European Discovery Trust NAV rises by 66 2% outperforming benchmark by 8 3%
directorstalkinterviews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from directorstalkinterviews.com Daily Mail and Mail on Sunday newspapers.

Investegate |Aberdeen New India Announcements | Aberdeen New India: Annual Financial Report

Brussels Regulatory Brief: May 2021 | K&L Gates LLP

The Biotech Growth Trust Plc - Annual Financial Report

The Biotech Growth Trust Plc - Annual Financial Report PR Newswire London, June 4 LONDON STOCK EXCHANGE ANNOUNCEMENT The Biotech Growth Trust PLC (the "Company") Audited

Investegate |Maven Inc &Grwth VCT Announcements | Maven Inc &Grwth VCT: Annual Financial Report

  • NAV at the year end of 44.41p per share (2020: 46.35p), after dividend payments totalling 3.00p per share during the year       • Deployment of £6.91 million during the year, including new investments in 20 private and AIM quoted companies       The financial year to 28 February 2021 has been a period of significant challenge and uncertainty dominated by the COVID-19 pandemic. This public health crisis has had a wide-reaching impact across our society, and the Directors thoughts are with all of those who have been affected.   Despite the economic disruption experienced during the year, it is encouraging to report that your Company has continued to make positive progress, with NAV total return increasing to 144.32p per share. This reflects the strength and resilience of the investee portfolio, where most companies successfully adjusted their business models to enable them to continue to operate under the lockdown restrictions. Further progress

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.